secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K/A
Filed at:   2024-06-25T23:59:59+00:00
Accession:  0000950170-24-077428
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix replaces auditor; EY out, CohnReznick in for FY2024
-------------------------------------------------------------

- Audit committee dismissed EY effective June 18, 2024; engaged CohnReznick LLP as new auditor for FY ending June 30, 2024.
- EY's reports for FY2023, 2022, 2021 had no adverse opinion, except a going-concern explanatory paragraph for FY2023.
- No disagreements with EY on accounting principles; past material weakness in stock-based compensation internal control was remediated by June 30, 2023.
- Auditor change part of cost-reduction and optimization of third-party support services.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024077428/0000950170-24-077428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024077428/rnlx-20240618.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-077428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer